__timestamp | Halozyme Therapeutics, Inc. | Lantheus Holdings, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 52602000 | 125519000 |
Thursday, January 1, 2015 | 105812000 | 135522000 |
Friday, January 1, 2016 | 113485000 | 137780000 |
Sunday, January 1, 2017 | 285461000 | 162135000 |
Monday, January 1, 2018 | 141726000 | 174885000 |
Tuesday, January 1, 2019 | 150446000 | 174811000 |
Wednesday, January 1, 2020 | 224227000 | 138761000 |
Friday, January 1, 2021 | 361897000 | 187695000 |
Saturday, January 1, 2022 | 520812000 | 581703000 |
Sunday, January 1, 2023 | 636892000 | 709543000 |
Monday, January 1, 2024 | 855907000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology and pharmaceuticals, understanding financial performance is crucial. Over the past decade, Halozyme Therapeutics, Inc. and Lantheus Holdings, Inc. have demonstrated remarkable growth in gross profit, reflecting their strategic advancements and market adaptability.
From 2014 to 2023, Halozyme's gross profit surged by over 1,100%, starting from a modest $52.6 million to an impressive $636.9 million. Meanwhile, Lantheus Holdings experienced a similar trajectory, with a 465% increase, reaching $709.5 million in 2023. Notably, both companies saw significant jumps in 2022, with Lantheus surpassing Halozyme for the first time in this period.
This financial ascent underscores the dynamic nature of the industry, where innovation and strategic positioning can lead to substantial economic gains. As these companies continue to evolve, their financial narratives offer valuable insights into the broader market trends.
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: BioMarin Pharmaceutical Inc. vs Lantheus Holdings, Inc.
Catalent, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Walgreens Boots Alliance, Inc. and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Exelixis, Inc. and Lantheus Holdings, Inc.
Who Generates Higher Gross Profit? Jazz Pharmaceuticals plc or Lantheus Holdings, Inc.
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Alkermes plc
Comparing SG&A Expenses: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc. Trends and Insights
Halozyme Therapeutics, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends